HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Differential effects of reduced mineralocorticoid receptor activation by unilateral adrenalectomy vs mineralocorticoid antagonist treatment in patients with primary aldosteronism - Implications for depression and anxiety.

Abstract
The mineralocorticoid receptor (MR) and its ligand aldosterone have been found to play a major role in the pathophysiology of depression. Both could be targets of therapeutic interventions. We analyzed laboratory data and questionnaires evaluating anxiety (using GAD-7 questionnaire) and depression (using PHQD questionnaire) of up to 210 patients with primary aldosteronism (PA) (82 females, 54.7 ± 12.0yrs; 128 males, 48.7 ± 12.8yrs) before and one year after initiation of specific treatment of PA by either adrenalectomy (ADX) or treatment with mineralocorticoid receptor antagonists (MRA). After ADX normalization of aldosterone excess was observed. This was associated with a significant reduction of depressive symptoms, but no significant change in GAD-7 score. MRA treatment was accompanied with persistent high aldosterone levels, but led to a significant improvement of anxiety, but no significant changes in PHQD scores. These data suggest different mechanistic pathways for depression and anxiety mediated via the MR. For treatment of depression a reduction of aldosterone levels might be relevant at CNS locations specific for aldosterone, whereas MRA targets MR more broadly, including areas, where cortisol is the main ligand. MRA may be useful in treatment of anxiety related behavior.
AuthorsHarald Murck, Christian Adolf, Anna Schneider, Lena Schlageter, Daniel Heinrich, Katrin Ritzel, Lisa Sturm, Marcus Quinkler, Felix Beuschlein, Martin Reincke, Heike Künzel
JournalJournal of psychiatric research (J Psychiatr Res) Vol. 137 Pg. 376-382 (05 2021) ISSN: 1879-1379 [Electronic] England
PMID33761426 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2021 Elsevier Ltd. All rights reserved.
Chemical References
  • Mineralocorticoid Receptor Antagonists
  • Mineralocorticoids
  • Receptors, Mineralocorticoid
  • Aldosterone
  • Renin
Topics
  • Adrenalectomy
  • Aldosterone
  • Anxiety (drug therapy, etiology)
  • Depression (drug therapy, etiology)
  • Female
  • Humans
  • Hyperaldosteronism (complications, drug therapy, surgery)
  • Male
  • Mineralocorticoid Receptor Antagonists
  • Mineralocorticoids
  • Receptors, Mineralocorticoid
  • Renin

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: